1. Incidence of Human Cytomegalovirus Infection in Patients with Refractory Solid Tumors Receiving Nonmyeloablative Allogeneic Stem Cell Transplants versus Recipients of Standard SCT for Hematologic Malignancies 
A. Zambelli, D. Lilleri, P. Pedrazzoli, J. Peccatori, F. Baldanti, V. Fregoni, F. Ciceri, D. Caldera, M. Renga, A.A. Colombo, E.P. Alessandrino, G. Gerna, G.A. Da Prada, S. Siena, M. Bregni 
Biology of Blood and Marrow Transplantation 
Volume 11, Issue 6, Pages (June 2005)
DOI: /j.bbmt
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence of HCMV infection in patients receiving NST for solid tumors as compared with patients receiving alloSCT for hematologic malignancies. HR indicates hazard ratio; CI, confidence interval.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions